Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
329 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (2)
  • Closed (3)

Medical Condition

  • Show all (1931)
  • Addiction (18)
  • Allergy, Asthma, & Immunology (13)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (28)
  • Blood Disorders (39)
  • Bone & Muscle (10)
  • Cancer (745)
    • Bladder Cancer (14)
    • Brain Cancer (25)
    • Breast Cancer (74)
    • Gastrointestinal (16)
    • Gynecologic Cancer (31)
    • Head and Neck Cancer (4)
    • Kidney Cancer (8)
    • Leukemia (77)
    • Liver Cancer (11)
    • Lung Cancer (64)
    • Lymphoma (45)
    • Multiple Myeloma (31)
    • Pancreatic Cancer (22)
    • Prostate Cancer (36)
    • Sarcoma (25)
    • Skin Cancer (30)
    • Solid Tumors (42)
    • (-) Thyroid Cancer (1)
    • Uveal Melanoma (7)
  • Child Development (4)
  • COVID-19 (Coronavirus) (36)
  • Critical Illness (1)
  • Diabetes (20)
  • Ear, Nose and Throat (11)
  • Endocrine & Metabolic Disease (11)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (25)
  • (-) Hair and Skin Disorders (3)
  • Headaches (5)
  • Healthy Volunteers (181)
  • Heart Disease (128)
  • Infectious Disease (48)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (49)
  • Lung Disease (31)
  • Meniere's Disease (1)
  • Neurological Disorders (178)
  • Nutrition (6)
  • Obesity (8)
  • Obstetrics & Gynecology (53)
    • (-) Abdominal Cramping (1)
    • Contraception (15)
    • Fertility (2)
    • Preeclampsia (1)
    • Pregnancy (17)
    • Prenatal Abnormalities (1)
    • Reproductive & Hormonal Disorders (2)
  • Pain Management (1)
  • Pediatrics (103)
  • Psychiatric Disorders (65)
  • Rehabilitation (8)
  • Stroke (6)
  • Surgery (7)
  • Transplant (53)
  • Urology (4)
  • Vascular Conditions (10)
Displaying 1 - 5 of 5

Insulin Action in Psoriasis

Condition: Hair and Skin Disorders
Investigator: Joshua Cook, MD, PhD
Status: Currently Recruiting
We are conducting a research study on how psoriasis might be caused or worsened by high levels of the blood sugar-lowering hormone insulin. We are seeking people with plaque psoriasis, ages 18-65, who are overweight or obese with a body mass index of 25-35. Participants will have blood drawn and small skin biopsies taken from psoriasis plaques and nearby…
Read More

Collection of Blood and Skin Samples from Patients with Hair and Skin Disorders

Condition: Hair and Skin Disorders
Investigator: Angela Christiano, PhD
Status: Currently Recruiting
The purpose of this study is to examine the causes and pathology of alopecia areata and other hair and skin disorders. Skin biopsies and blood and/or clinical information collected in the study will be used for research aiming at developing new options for the treatment of alopecia areata and other skin and hair disorders.
Read More

Genetic Studies of Hidradenitis Suppurativa

Condition: Hair and Skin Disorders
Investigator: Lynn Petukhova, PhD
Status: Closed
Genetic studies help us to understand why some people develop certain diseases while others don't and also provide important clues about how best to treat the disease.
Read More

A study for women with moderate to severe abdominal cramping during menstruation using a new hormonal vaginal ring

Condition: Obstetrics & Gynecology / Abdominal Cramping
Investigator: Anne Davis, MD
Status: Closed
You may be eligible if you are younger than 51 years old, have regular monthly periods with moderate to severe cramping, and are willing to try a NEW hormonal vaginal ring. The ring contains estrogen and progestin which are hormones found in some types of birth control pills, patches and rings.Participation in the study will consist of 6 study visits and 2…
Read More

Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer

Condition: Cancer / Thyroid Cancer
Investigator: Antonio Fojo, MD, PhD
Status: Closed
This is a study designed for patients with medullary thyroid cancer. Treatment will consist of a drug called Ponatinib. Ponatinib is an investigational agent that blocks abnormal cancer proteins and therefore harms cancer cells. It was recently approved by the Food and Drug Administration for leukemia treatment, but is not approved for medullary thyroid…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science